Treatment: Chronic Hepatitis B

There are currently seven approved drugs for the treatment of chronic HBV: interferon α (IFN-α), pegylated interferon (PEG IFN), lamivudine, adefovir dipivoxil, entecavir, telbivudine, and tenofovir (see Table 153-1).Use of IFN-α has been supplanted by PEG-IFN. Table 153-2 summarizes recommendations for treatment of chronic HBV.